Table 1.

Percentages of complete cure, adverse effects during treatment, and recurrence rates for the three treatments.

	3% Diclofenac	Ingenol mebutate	3.75% Imiquimod
Probability of adverse effects	5%	2.2%	3.6%
Probability of a complete cure	58%	42.2%	35.6%
Probability of recurrence at 12 months	21%	12.8%	20.9%

Data are derived for 3% diclofenac from Nelson and Rigel,⁹ for ingenol mebutate from Lebwohl et al.,⁶ and for 3.75% imiquimod from Swanson et al.¹¹